Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials

    July 2023 in “Cureus
    Parth S Bajoria, Paresh Dave, Ralph Kingsford Rohit, Charu Tibrewal, Neena Modi, Seema Gandhi, Priyansh Patel
    Image of study
    TLDR Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.
    The review "Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials" analyzed 35 studies from 2013 to 2023 on Androgenetic Alopecia (AGA), a hereditary hair loss condition linked to elevated dihydrotestosterone (DHT) levels and androgen receptor gene expression. FDA-approved treatments like topical minoxidil and oral finasteride have shown effectiveness, but their efficacy varies among patients and they can have side effects. Non-pharmacological treatments like Low-Level Laser Therapy (LLLT) and Platelet-Rich Plasma (PRP) therapy have shown promise, but require more rigorous trials. Newer treatments like 0.2% topical caffeine-based solutions, topical cetirizine 1%, adipose tissue-derived stem cells (ADSCs), botulinum toxin (BT) type A, and herbal shampoos and solutions are being explored. Hair transplantation has over 90% graft survival. However, a definitive treatment for AGA is yet to be found. Emerging therapies like gene therapies, stem cell-based treatments, and novel pharmaceutical agents require rigorous evaluation for safety, efficacy, and long-term outcomes. The review calls for larger, longer studies as most clinical trials were short and had small sample sizes.
    View this study on assets.cureus.com →

    Cited in this study

    Related